Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid) - PubMed (original) (raw)
Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid)
M C Bibby et al. Br J Cancer. 1987 Feb.
Free PMC article
Abstract
LM985 has been shown previously to hydrolyse to flavone acetic acid (LM975) in mouse plasma and to produce significant anti-tumour effects in transplantable mouse colon tumours (MAC). It has undergone Phase I clinical trials and dose limiting toxicity was acute reversible hypotension. Substantially higher doses of LM975 can be given clinically without dose limiting toxicity. We have investigated the activity of LM975 against a panel of MAC tumours and also the in vitro cytotoxicity of both LM985 and LM975 in two cell lines derived from MAC tumours. LM985 is considerably more cytotoxic than LM975 in vitro but increased length of exposure to LM975 results in improved activity. Single in vivo injection of LM975 showed no activity against the ascitic tumour MAC 15A, moderate activity against the s.c. poorly differentiated tumour MAC 13 and produced a significant growth delay in the well differentiated MAC 26. These latter responses were considerably enhanced by repeated injection 7 days later. Pharmacokinetic studies in mice following i.p. injection of LM985 demonstrated rapid degradation of LM985 to LM975 in the peritoneum. Length of exposure as well as drug concentration appear important factors in determining anti-tumour responses.
Similar articles
- Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
Double JA, Bibby MC, Loadman PM. Double JA, et al. Br J Cancer. 1986 Oct;54(4):595-600. doi: 10.1038/bjc.1986.214. Br J Cancer. 1986. PMID: 3778803 Free PMC article. - In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).
Schroyens WA, Dodion PF, Sanders C, Loos M, Dethier NE, Delforge AR, Stryckmans PA, Kenis Y. Schroyens WA, et al. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1135-9. doi: 10.1016/0277-5379(87)90146-5. Eur J Cancer Clin Oncol. 1987. PMID: 3653209 - Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).
Kerr DJ, Kaye SB, Graham J, Cassidy J, Harding M, Setanoians A, McGrath JC, Vezin WR, Cunningham D, Forrest G, et al. Kerr DJ, et al. Cancer Res. 1986 Jun;46(6):3142-6. Cancer Res. 1986. PMID: 3698028 - Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
Bibby MC, Phillips RM, Double JA. Bibby MC, et al. Cancer Chemother Pharmacol. 1989;24(2):87-94. doi: 10.1007/BF00263126. Cancer Chemother Pharmacol. 1989. PMID: 2731316 - Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
Bibby MC, Double JA, Loadman PM. Bibby MC, et al. Br J Cancer. 1988 Sep;58(3):341-4. doi: 10.1038/bjc.1988.215. Br J Cancer. 1988. PMID: 3179187 Free PMC article.
Cited by
- Biocompatible Alginate Hydrogel Film Containing Acetic Acid Manifests Broad-Spectrum Antiviral and Anticancer Activities.
Cano-Vicent A, Tuñón-Molina A, Bakshi H, Alfagih IM, Tambuwala MM, Serrano-Aroca Á. Cano-Vicent A, et al. Biomedicines. 2023 Sep 16;11(9):2549. doi: 10.3390/biomedicines11092549. Biomedicines. 2023. PMID: 37760990 Free PMC article. - Effect of ethyl acetate aroma on viability of human breast cancer and normal kidney epithelial cells in vitro.
Khan MA, Ahmad R, Srivastava AN. Khan MA, et al. Integr Med Res. 2017 Mar;6(1):47-59. doi: 10.1016/j.imr.2016.11.004. Epub 2016 Dec 12. Integr Med Res. 2017. PMID: 28462144 Free PMC article. - Crystal structure elucidation and anticancer studies of (-)-pseudosemiglabrin: a flavanone isolated from the aerial parts of Tephrosia apollinea.
Ahmed Hassan LE, Khadeer Ahamed MB, Abdul Majid AS, Iqbal MA, Al Suede FS, Haque RA, Ismail Z, Ein OC, Majid AM. Ahmed Hassan LE, et al. PLoS One. 2014 Mar 7;9(6):e90806. doi: 10.1371/journal.pone.0090806. eCollection 2014. PLoS One. 2014. PMID: 24608571 Free PMC article. - Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.
Newell DR, Searle KM, Westwood NB, Burtles SS; Cancer Research UK Phase I/II Clinical Trials Committee. Newell DR, et al. Br J Cancer. 2003 Aug 4;89(3):437-54. doi: 10.1038/sj.bjc.6601106. Br J Cancer. 2003. PMID: 12888809 Free PMC article. No abstract available. - Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy.
Kragh M, Quistorff B, Horsman MR, Kristjansen PE. Kragh M, et al. Neoplasia. 2002 May-Jun;4(3):263-7. doi: 10.1038/sj.neo.7900230. Neoplasia. 2002. PMID: 11988846 Free PMC article.
References
- J Natl Cancer Inst. 1975 Jan;54(1):271-5 - PubMed
- Cancer Chemother Rep. 1975 Nov-Dec;59(6):1083-9 - PubMed
- Br J Cancer. 1986 Oct;54(4):595-600 - PubMed
- Cancer Res. 1986 Jun;46(6):3142-6 - PubMed
- Cancer Treat Rep. 1986 May;70(5):631-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources